Counterfeiting trends in the pharmaceutical industry

The Pharmaceutical Security Institute (PSI) has as its top priority, the protection of the public health through the disruption and dismantling of criminal groups involved in counterfeit pharmaceuticals. To that end the PSI works closely with the WCO, Customs administrations, other law enforcement agencies and drug regulatory authorities. While some sense of the global counterfeiting problem is conveyed by well publicised cases, too often the availability of counterfeiting data is limited even at times dubious, overly optimistic, very pessimistic, or highly questionable estimates are presented as fact.